July 2011 - FRMC

Feature

07/19/2011

Tim Casey

Chicago—In a randomized, multicenter phase 3b trial, 3 bortezomib-based therapies had similar rates of progression-free survival and were active in treating patients with newly diagnosed multiple myeloma (MM) who were ineligible to receive...

Chicago—In a randomized,...

07/19/2011

First Report Managed Care

Feature

Comparison of Myeloablative Therapies for Children with High-Risk Neuroblastoma

07/19/2011

Tim Casey

Chicago—Children with high-risk neuroblastoma who took busulphan and melphalan (BUMEL) had significantly improved event-free survival and overall survival after 3 years compared with a group that received carboplatin, etoposide, and melphalan...

Chicago—Children with high-risk...

07/19/2011

First Report Managed Care

Vemurafenib Plus Dacarbazine Improves Survival in Metastatic Melanoma Patients

07/19/2011

Tim Casey

Chicago—A phase 3 study presented in the plenary session at the ASCO meeting showed that patients with previously untreated metastatic melanoma who received vemurafenib plus dacarbazine (a chemotherapy agent) had prolonged survival compared...

Chicago—A phase 3 study...

07/19/2011

First Report Managed Care

Feature

Patients with Metastatic Melanoma Benefit from Vemurafenib

07/19/2011

Tim Casey

Chicago—Patients with untreated metastatic melanoma who took vemurafenib had significant improvements in overall and progression-free survival compared with a group that took dacarbazine, according to a phase 3 trial presented in a plenary...

Chicago—Patients with untreated...

07/19/2011

First Report Managed Care

Feature

Ruxolitinib in Patients with Myelofibrosis

07/19/2011

Tim Casey

Chicago—A phase 3 trial found that ruxolitinib showed a clinical benefit in reducing spleen size and significantly improved disease-related symptoms, functioning, and quality of life in patients with myelofibrosis compared with the best...

Chicago—A phase 3 trial found...

07/19/2011

First Report Managed Care

Feature

Abiraterone Acetate Improves Survival in Prostate Cancer Patients

07/19/2011

Tim Casey

Chicago—A phase 3 study found that patients taking abiraterone acetate had a median increase in survival of 4.5 months compared with placebo and that the level of circulating tumor cells (CTCs) correlated with survival. Howard Scher, MD, the...

Chicago—A phase 3 study found...

07/19/2011

First Report Managed Care

Feature

Combination of Erlotinib and Pemetrexed to Treat Non–Small-Cell Lung Cancer

07/19/2011

Tim Casey

Chicago—A multicenter, open-label, randomized phase 2 study found that patients with nonsquamous, non–small-cell lung cancer (NSCLC) who took erlotinib and pemetrexed as a second-line treatment had significant improvements in overall survival...

Chicago—A multicenter,...

07/19/2011

First Report Managed Care

Feature

3 Years versus 1 Year of Imatinib Treatment in Patients with GISTs

07/19/2011

Tim Casey

Patients with high-risk gastrointestinal stromal tumors who received imatinib after undergoing surgery had improved survival.

Patients with high-risk...

07/19/2011

First Report Managed Care

Feature

Exemestane Reduces Breast Cancer Risk for Postmenopausal Women

07/19/2011

Tim Casey

Chicago—A randomized, double-blind, placebo-controlled, phase 3 study presented in an oral abstract session at the ASCO meeting revealed that exemestane reduced the risk of invasive breast cancer by 65% in postmenopausal women who are at high...

Chicago—A randomized,...

07/19/2011

First Report Managed Care

Feature

Bevacizumab Superior to Placebo in Treating Ovarian Cancer Patients

07/19/2011

Tim Casey

Chicago—At a median follow-up of 24 months, patients with recurrent platinum-sensitive ovarian cancer who took bevacizumab in combination with chemotherapy had a 52% reduction in the risk of disease progression and a 4-month increase in...

Chicago—At a median follow-up of...

07/19/2011

First Report Managed Care

Current Issue

June 2024

Volume 21

Issue 2

Current Issue

Issue Archive

What's Trending?

Conference Insider

Managing Chronic Kidney Disease in Older Adults

11/03/2014

Eileen Koutnik-Fotopoulos

Chronic kidney disease is pervasive in the older population. The progression of CKD can have a significant affect on the overall prognosis of a geriatric patient.

Chronic kidney disease is...

11/03/2014

First Report Managed Care

News

Retirement, health insurance commonly targeted

08/04/2011

First Report Managed Care

News

US Government Proposes More Transparency in Clinical Trials

11/19/2014

Health officials proposed significantly expanding what researchers are required to report about clinical trials of drugs, devices, and other interventions.

Health officials proposed...

11/19/2014

First Report Managed Care

News

Device Could Reduce Direct Medical Costs For Patients with COPD

11/15/2017

Recent research in the International Journal of COPD found that a handheld mechanical oscillating positive expiratory pressure device could significantly improve post-exacerbation care.

Recent research in...

11/15/2017

First Report Managed Care

News

Pelosi: Public option will not be in health bill despite liberal efforts

03/12/2010

First Report Managed Care

Video Insights

Videos

Evolving Health Care Contact Centers Into Drivers of Value-Based Care

07/31/2024

Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.

Discover how health care contact...

07/31/2024

First Report Managed Care

Videos

Enhancing Patient Medication Adherence: Insights and Strategies From Asembia 2024

06/11/2024

Lucille Accetta, PharmD, MBA, MSPH, Senior Vice President of CVS Specialty Operations

Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...

Key stakeholders in the health...

06/11/2024

First Report Managed Care

Melissa Andel, Principal, CommonHealth Solutions, LLC

Videos

Navigating the Impact of the Inflation Reduction Act: Implications for Payers, Patients, and Manufacturers

05/24/2024

Melissa Andel, Principal, CommonHealth Solutions, LLC

Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.

Learn about the impacts of the...

05/24/2024

First Report Managed Care

Videos

Navigating Payment Models in the CGT Landscape: Insights and Innovations

05/21/2024

Joe DePinto, Head of Cell, Gene, and Advanced Therapies, McKesson

An expert discusses the evolution and challenges of payment models in the cell and gene therapy (CGT) space reviewed during his session at Asembia 2024.

An expert discusses the...

05/21/2024

First Report Managed Care

Jennifer L. Mathieu Senior Vice President, Professional and Government Affairs at AMCP

Videos

Unlocking the Future of Managed Care Pharmacy: A Deep Dive into Federal Legislation and Regulations

05/15/2024

Jennifer L. Mathieu Senior Vice President, Professional and Government Affairs, AMCP

Learn about developments in federal legislation and regulations within the pharmacy landscape shaping the future of managed care in an interview with a session presenter from AMCP 2024.

Learn about developments in...

05/15/2024

First Report Managed Care

Videos

Personalizing Weight Loss Management With GLP-1 Agonists

04/05/2024

Featuring Tejaswi Kompala, MD, head of cardiometabolic clinical strategy, Teladoc

Featuring Tejaswi Kompala, MD, head o...

Delve into the rising demand for anti-obesity medications, the complexities of obesity management, and the importance of personalized approaches in improving cardiometabolic health in this insightful interview.

Delve into the rising demand for...

04/05/2024

First Report Managed Care

Videos

Integrating Behavioral Health Services to Reduce ED Visits: Substance Use Disorder and Social Determinants of Health

03/27/2024

Featuring Tom Zaubler, MD, MPH, CMO at NeuroFlow

Featuring Tom Zaubler, MD, MPH, CMO a...

Join us for the continuation of an engaging two-part series showcasing an expert dedicated to reducing emergency department visits through the integration of behavioral health practices. Dr Zaubler will share invaluable insights into...

Join us for the continuation of...

03/27/2024

First Report Managed Care

Videos

Integrating Behavioral Health Services to Reduce ED Visits: Suicide Prevention and Preemptive Primary Care

03/25/2024

Featuring Tom Zaubler, MD, MPH, CMO at NeuroFlow

Featuring Tom Zaubler, MD, MPH, CMO a...

Come join us for the first installment of a captivating two-part series featuring an expert committed to minimizing emergency department visits through the implementation of behavioral health integrations. Dr Zaubler will offer valuable...

Come join us for the first...

03/25/2024

First Report Managed Care

Videos

Navigating the Evolution of Digital Solutions in Health Care

02/27/2024

Featuring Yash Prajapati, consultant at ZS Associates

Featuring Yash Prajapati, consultant ...

Join us in exploring the challenges and opportunities in the development, approval, and integration of digital therapeutic solutions with ZS Associates consultant Yash Prajapati.

Join us in exploring the...

02/27/2024

First Report Managed Care

Videos

Advancements and Challenges in Diabetes Management

02/27/2024

Featuring Mansur Shomali, MD, chief medical officer at Welldoc, endocrinologist at MedStar Health

Featuring Mansur Shomali, MD, chief m...

Learn about the state of digital therapeutics for disease management such as diabetes care in terms of cost, outcomes, integration, and more with Dr Mansur Shomali, CMO at Welldoc.

July 2011 - FRMC

Current Issue

What's Trending?

Video Insights

Subscribe to our eNewsletters!

July 2011 Volume 8 Issue 7

Specialties

Events

Year Round Education

HMP Global Products